Synthesized peptide derived from human RN213. AA range:307-407

This antibody detects endogenous levels of RN213 at Human/Mouse

RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR

RN213

This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011],

Disease:A chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALK.,sequence Caution:Translated as Gln.,similarity:Contains 1 RING-type zinc finger.,

Cytoplasm, cytosol . Lipid droplet .

Widely expressed (at protein level). ; [Isoform 1]: Major isoform detected in all tissues examined. ; [Isoform 2]: Minor isoform with restricted expression.